Form 13-F position report

MEDPACE HLDGS INC

Reported by RICE HALL JAMES & ASSOCIATES LLC

MEDP CUSIP 58506Q109 Manager CIK 0001230765

Reported 52,852 shares, down 1,264 (2.3%) from the prior quarter.

Reported value 15.1%; share count -2.3% vs. the prior quarter.

Reduced
% of reported 13F value 1.75% This manager · Q3 2026
Shares 52,852 Quarter-end amount reported
Reported value $32,989,161 Fair value at quarter end
Consecutive quarters held 24 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 35622000
2022-03-31 30028000
2022-06-30 28010000
2022-09-30 32365000
2022-12-31 42110495
2023-03-31 33069021
2023-06-30 33963722
2023-09-30 31982225
2023-12-31 39125489
2024-03-31 49259823
2024-06-30 46740445
2024-09-30 36650239
2024-12-31 34712387
2025-03-31 31421766
2025-06-30 32156212
2025-09-30 46998851
2025-12-31 35110988
2026-03-31 25922097
2026-06-30 28659292
2026-09-30 32989161

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for MEDPACE HLDGS INC held by RICE HALL JAMES & ASSOCIATES LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 52,852 -1,264 (-2.3%) 1.75% $32,989,161 2026-11-16
Q2 2026 Added 54,116 +133 (0.2%) 1.39% $28,659,292 2026-08-07
Q1 2026 Reduced 53,983 -8,531 (-13.6%) 1.44% $25,922,097 2026-05-15
Q4 2025 Reduced 62,514 -28,895 (-31.6%) 1.93% $35,110,988 2026-02-17
Q3 2025 Reduced 91,409 -11,045 (-10.8%) 2.56% $46,998,851 2025-10-16
Q2 2025 Reduced 102,454 -673 (-0.7%) 1.73% $32,156,212 2025-08-11
Q1 2025 Reduced 103,127 -1,356 (-1.3%) 1.85% $31,421,766 2025-05-01
Q4 2024 Reduced 104,483 -5,314 (-4.8%) 1.91% $34,712,387 2025-01-31
Q3 2024 Reduced 109,797 -3,692 (-3.3%) 1.98% $36,650,239 2024-10-28
Q2 2024 Reduced 113,489 -8,396 (-6.9%) 2.8% $46,740,445 2024-08-07
Q1 2024 Reduced 121,885 -5,755 (-4.5%) 2.81% $49,259,823 2024-04-23
Q4 2023 Reduced 127,640 -4,447 (-3.4%) 2.27% $39,125,489 2024-02-09
Q3 2023 Reduced 132,087 -9,328 (-6.6%) 2.03% $31,982,225 2023-11-02
Q2 2023 Reduced 141,415 -34,437 (-19.6%) 1.93% $33,963,722 2023-07-24
Q1 2023 Reduced 175,852 -22,399 (-11.3%) 1.88% $33,069,021 2023-05-12
Q4 2022 Reduced 198,251 -7,671 (-3.7%) 2.42% $42,110,495 2023-01-27
Q3 2022 Added 205,922 +18,777 (10.0%) 1.88% $32,365,000 2022-11-01
Q2 2022 Added 187,145 +3,589 (2.0%) 1.35% $28,010,000 2022-08-08
Q1 2022 Added 183,556 +19,884 (12.1%) 1.2% $30,028,000 2022-05-05
Q4 2021 Reduced 163,672 -4,160 (-2.5%) 1.26% $35,622,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

814 managers reported MEDPACE HLDGS INC for Q3 2026.

Managers reporting MEDPACE HLDGS INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 2,562,937 +64,689 0.02% $1,599,734,025 9 qtrs
AQR CAPITAL MANAGEMENT LLC Added 1,396,654 +117,719 0.26% $863,222,956 35 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 1,136,249 -933,428 0.07% $709,225,000 33 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Reduced 1,085,294 -48,063 0.03% $677,418,809 3 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Reduced 1,005,976 -20,844 0.01% $627,910,100 3 qtrs
STATE STREET CORPORATION Added 714,316 +3,421 0.01% $445,861,761 41 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 712,423 +1,958 0.02% $444,747,242 41 qtrs
Invesco Ltd Reduced 501,572 -77,669 0.02% $313,071,212 41 qtrs
ARROWSTREET CAPITAL LIMITED PARTNERSHIP Added 499,798 +70,786 0.13% $311,963,916 29 qtrs
WASATCH ADVISORS INC Reduced 465,944 -170,651 2.16% $290,832,926 32 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
40,149
Shared
0
None
12,703

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.